National Research Corporation (NRC)
USD 17.18
(-2.83%)
USD 17.18
(-2.83%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 38.95 Million USD | 75.63% |
| 2022 | 22.18 Million USD | -16.45% |
| 2021 | 26.54 Million USD | -13.27% |
| 2020 | 30.6 Million USD | -10.43% |
| 2019 | 34.17 Million USD | 831.91% |
| 2018 | 3.66 Million USD | 243.67% |
| 2017 | 1.06 Million USD | -60.23% |
| 2016 | 2.68 Million USD | 11.7% |
| 2015 | 2.4 Million USD | 3.18% |
| 2014 | 2.32 Million USD | 3.19% |
| 2013 | 2.25 Million USD | -81.86% |
| 2012 | 12.43 Million USD | 568.24% |
| 2011 | 1.86 Million USD | 1.86% |
| 2010 | 1.82 Million USD | 123.9% |
| 2009 | 816 Thousand USD | -82.19% |
| 2008 | 4.58 Million USD | 53.04% |
| 2007 | 2.99 Million USD | -73.02% |
| 2006 | 11.09 Million USD | 654.11% |
| 2005 | 1.47 Million USD | -69.98% |
| 2004 | 4.9 Million USD | -2.82% |
| 2003 | 5.04 Million USD | -2.57% |
| 2002 | 5.17 Million USD | -2.38% |
| 2001 | 5.3 Million USD | -2.36% |
| 2000 | 5.43 Million USD | 50.84% |
| 1999 | 3.6 Million USD | 3500.0% |
| 1998 | 100 Thousand USD | 0.0% |
| 1997 | - USD | 0.0% |
| 1996 | - USD | 0.0% |
| 1995 | - USD | 0.0% |
| 1994 | - USD | 0.0% |
| 1993 | - USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | 42.07 Million USD | 8.0% |
| 2024 Q2 | 42.22 Million USD | 0.35% |
| 2024 Q3 | 53.63 Million USD | 27.02% |
| 2023 Q4 | 38.95 Million USD | 63.48% |
| 2023 FY | 38.95 Million USD | 75.63% |
| 2023 Q3 | 23.82 Million USD | 19.36% |
| 2023 Q2 | 19.96 Million USD | -5.28% |
| 2023 Q1 | 21.07 Million USD | -4.98% |
| 2022 Q1 | 25.49 Million USD | -3.97% |
| 2022 Q2 | 24.43 Million USD | -4.16% |
| 2022 Q3 | 23.27 Million USD | -4.76% |
| 2022 Q4 | 22.18 Million USD | -4.68% |
| 2022 FY | 22.18 Million USD | -16.45% |
| 2021 Q4 | 26.54 Million USD | -3.76% |
| 2021 Q1 | 29.6 Million USD | -3.27% |
| 2021 Q2 | 28.6 Million USD | -3.39% |
| 2021 FY | 26.54 Million USD | -13.27% |
| 2021 Q3 | 27.58 Million USD | -3.56% |
| 2020 Q1 | 33.22 Million USD | -2.78% |
| 2020 Q2 | 32.59 Million USD | -1.9% |
| 2020 Q3 | 31.59 Million USD | -3.07% |
| 2020 Q4 | 30.6 Million USD | -3.11% |
| 2020 FY | 30.6 Million USD | -10.43% |
| 2019 Q4 | 34.17 Million USD | -2.67% |
| 2019 Q3 | 35.11 Million USD | -5.18% |
| 2019 Q2 | 37.02 Million USD | -4.29% |
| 2019 Q1 | 38.68 Million USD | 955.0% |
| 2019 FY | 34.17 Million USD | 831.91% |
| 2018 Q3 | 38.93 Million USD | -1.91% |
| 2018 Q4 | 3.66 Million USD | -90.58% |
| 2018 Q2 | 39.69 Million USD | 74788.68% |
| 2018 Q1 | 53 Thousand USD | -95.03% |
| 2018 FY | 3.66 Million USD | 243.67% |
| 2017 Q4 | 1.06 Million USD | -40.06% |
| 2017 FY | 1.06 Million USD | -60.23% |
| 2017 Q1 | 2.82 Million USD | 5.29% |
| 2017 Q2 | 2.2 Million USD | -21.81% |
| 2017 Q3 | 1.78 Million USD | -19.42% |
| 2016 FY | 2.68 Million USD | 11.7% |
| 2016 Q1 | 5.21 Million USD | 116.99% |
| 2016 Q2 | 4.62 Million USD | -11.19% |
| 2016 Q3 | 2.46 Million USD | -46.86% |
| 2016 Q4 | 2.68 Million USD | 9.07% |
| 2015 FY | 2.4 Million USD | 3.18% |
| 2015 Q2 | 7.02 Million USD | -7.72% |
| 2015 Q4 | 2.4 Million USD | -62.51% |
| 2015 Q3 | 6.4 Million USD | -8.8% |
| 2015 Q1 | 7.61 Million USD | 227.02% |
| 2014 Q4 | 2.32 Million USD | 0.78% |
| 2014 Q2 | 9.37 Million USD | 312.54% |
| 2014 Q1 | 2.27 Million USD | 0.75% |
| 2014 FY | 2.32 Million USD | 3.19% |
| 2014 Q3 | 2.31 Million USD | -75.37% |
| 2013 Q2 | 11.71 Million USD | -4.1% |
| 2013 Q4 | 2.25 Million USD | -79.46% |
| 2013 Q1 | 12.21 Million USD | -1.78% |
| 2013 FY | 2.25 Million USD | -81.86% |
| 2013 Q3 | 10.98 Million USD | -6.21% |
| 2012 Q3 | 13.07 Million USD | 524.75% |
| 2012 Q2 | 2.09 Million USD | 1.01% |
| 2012 Q1 | 2.07 Million USD | -86.01% |
| 2012 Q4 | 12.43 Million USD | -4.89% |
| 2012 FY | 12.43 Million USD | 568.24% |
| 2011 Q4 | 14.81 Million USD | 688.66% |
| 2011 Q2 | 3.26 Million USD | -79.24% |
| 2011 Q1 | 15.7 Million USD | -2.8% |
| 2011 FY | 1.86 Million USD | 1.86% |
| 2011 Q3 | 1.87 Million USD | -42.39% |
| 2010 Q1 | 808 Thousand USD | -89.53% |
| 2010 FY | 1.82 Million USD | 123.9% |
| 2010 Q3 | 1.8 Million USD | 120.88% |
| 2010 Q4 | 16.16 Million USD | 793.31% |
| 2010 Q2 | 819 Thousand USD | 1.36% |
| 2009 Q1 | 11 Million USD | -15.02% |
| 2009 Q2 | 820 Thousand USD | -92.55% |
| 2009 Q3 | 765 Thousand USD | -6.71% |
| 2009 Q4 | 7.71 Million USD | 909.02% |
| 2009 FY | 816 Thousand USD | -82.19% |
| 2008 Q4 | 12.95 Million USD | 5313.42% |
| 2008 Q3 | 239.29 Thousand USD | -92.65% |
| 2008 Q2 | 3.25 Million USD | -50.79% |
| 2008 Q1 | 6.61 Million USD | 121.06% |
| 2008 FY | 4.58 Million USD | 53.04% |
| 2007 FY | 2.99 Million USD | -73.02% |
| 2007 Q1 | 8.33 Million USD | -24.86% |
| 2007 Q2 | 6.76 Million USD | -18.87% |
| 2007 Q3 | 4.81 Million USD | -28.8% |
| 2007 Q4 | 2.99 Million USD | -37.83% |
| 2006 Q4 | 11.09 Million USD | 269.65% |
| 2006 FY | 11.09 Million USD | 654.11% |
| 2006 Q1 | 200 Thousand USD | -86.4% |
| 2006 Q3 | 3 Million USD | -76.37% |
| 2006 Q2 | 12.7 Million USD | 6250.0% |
| 2005 Q4 | 1.47 Million USD | -69.25% |
| 2005 Q2 | 4.82 Million USD | -0.8% |
| 2005 Q1 | 4.86 Million USD | -0.8% |
| 2005 FY | 1.47 Million USD | -69.98% |
| 2005 Q3 | 4.78 Million USD | -0.8% |
| 2004 FY | 4.9 Million USD | -2.82% |
| 2004 Q4 | 4.9 Million USD | -0.73% |
| 2004 Q3 | 4.93 Million USD | -0.71% |
| 2004 Q2 | 4.97 Million USD | -0.71% |
| 2004 Q1 | 5 Million USD | -0.69% |
| 2003 Q1 | 5.14 Million USD | -0.65% |
| 2003 Q2 | 5.1 Million USD | -0.64% |
| 2003 Q3 | 5.07 Million USD | -0.64% |
| 2003 Q4 | 5.04 Million USD | -0.67% |
| 2003 FY | 5.04 Million USD | -2.57% |
| 2002 Q2 | 5.24 Million USD | -0.55% |
| 2002 Q3 | 5.2 Million USD | -0.77% |
| 2002 FY | 5.17 Million USD | -2.38% |
| 2002 Q4 | 5.17 Million USD | -0.59% |
| 2002 Q1 | 5.27 Million USD | -0.49% |
| 2001 Q2 | 5.36 Million USD | -0.59% |
| 2001 Q4 | 5.3 Million USD | -0.6% |
| 2001 Q3 | 5.33 Million USD | -0.59% |
| 2001 Q1 | 5.39 Million USD | -0.6% |
| 2001 FY | 5.3 Million USD | -2.36% |
| 2000 FY | 5.43 Million USD | 50.84% |
| 2000 Q1 | 4.07 Million USD | 13.07% |
| 2000 Q3 | 5.72 Million USD | -0.07% |
| 2000 Q4 | 5.43 Million USD | -5.13% |
| 2000 Q2 | 5.72 Million USD | 40.71% |
| 1999 Q1 | 1.6 Million USD | 1500.0% |
| 1999 FY | 3.6 Million USD | 3500.0% |
| 1999 Q2 | 100 Thousand USD | -93.75% |
| 1999 Q4 | 3.6 Million USD | 71.43% |
| 1999 Q3 | 2.1 Million USD | 2000.0% |
| 1998 Q2 | 100 Thousand USD | 0.0% |
| 1998 FY | 100 Thousand USD | 0.0% |
| 1998 Q1 | - USD | 0.0% |
| 1998 Q4 | 100 Thousand USD | 0.0% |
| 1998 Q3 | 100 Thousand USD | 0.0% |
| 1997 FY | - USD | 0.0% |
| 1997 Q4 | - USD | 0.0% |
| 1996 FY | - USD | 0.0% |
| 1995 FY | - USD | 0.0% |
| 1994 FY | - USD | 0.0% |
| 1993 FY | - USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Inovalon Holdings, Inc. | 897.3 Million USD | 95.659% |
| GE HealthCare Technologies Inc. | 9.86 Billion USD | 99.605% |
| Sharecare, Inc. | 2.34 Million USD | -1561.237% |
| Progyny, Inc. | 19.39 Million USD | -100.908% |
| Aclarion, Inc. | 1.12 Million USD | -3360.529% |
| CareMax, Inc. | 491.93 Million USD | 92.081% |
| Simulations Plus, Inc. | 475 Thousand USD | -8101.263% |
| CareCloud, Inc. | 14.73 Million USD | -164.413% |
| Forian Inc. | 23 Million USD | -69.361% |
| Bullfrog AI Holdings, Inc. Warrants | - USD | -Infinity% |
| Bullfrog AI Holdings, Inc. Common Stock | - USD | -Infinity% |
| Minerva Surgical, Inc. | 39.69 Million USD | 1.849% |
| Omnicell, Inc. | 614.09 Million USD | 93.656% |
| Definitive Healthcare Corp. | 267.92 Million USD | 85.46% |
| Zhongchao Inc. | 808.15 Thousand USD | -4720.356% |
| Accolade, Inc. | 241.64 Million USD | 83.879% |
| Streamline Health Solutions, Inc. | 10.56 Million USD | -268.692% |
| Ontrak, Inc. | 1.68 Million USD | -2206.454% |
| SOPHiA GENETICS SA | 18.6 Million USD | -109.43% |
| R1 RCM Inc. | 1.74 Billion USD | 97.762% |
| Spok Holdings, Inc. | 11.08 Million USD | -251.398% |
| Privia Health Group, Inc. | 8.28 Million USD | -369.972% |
| EUDA Health Holdings Limited | 3.37 Million USD | -1054.414% |
| HeartBeam, Inc. | - USD | -Infinity% |
| GeneDx Holdings Corp. | 119.77 Million USD | 67.474% |
| TruBridge, Inc. | 203.28 Million USD | 80.837% |
| Nutex Health, Inc. | 275.75 Million USD | 85.873% |
| Renalytix Plc | 8.53 Million USD | -356.426% |
| Sharecare, Inc. | 2.34 Million USD | -1561.237% |
| Health Catalyst, Inc. | 249.06 Million USD | 84.359% |
| 10x Genomics, Inc. | 95.37 Million USD | 59.153% |
| GoodRx Holdings, Inc. | 711.07 Million USD | 94.521% |
| SCWorx Corp. | 90.35 Thousand USD | -43012.474% |
| Schrödinger, Inc. | 127.88 Million USD | 69.538% |
| HealthEquity, Inc. | 933.14 Million USD | 95.825% |
| HealthStream, Inc. | 23.22 Million USD | -67.762% |
| MSP Recovery, Inc. | 679.32 Million USD | 94.266% |
| Augmedix, Inc. | 25.84 Million USD | -50.724% |
| BrightSpring Health Services, Inc. Common Stock | 3.67 Billion USD | 98.939% |
| Ontrak, Inc. | 1.68 Million USD | -2206.454% |
| SHL Telemedicine Ltd. | 19.85 Million USD | -96.241% |
| CareCloud, Inc. | 14.73 Million USD | -164.413% |
| Premier, Inc. | 126 Million USD | 69.083% |
| Certara, Inc. | 298.19 Million USD | 86.936% |
| GeneDx Holdings Corp. | 119.77 Million USD | 67.474% |
| OneMedNet Corporation | 5.1 Million USD | -663.646% |
| BrightSpring Health Services, Inc. Tangible Equity Unit | 3.67 Billion USD | 98.939% |
| EUDA Health Holdings Limited | 3.37 Million USD | -1054.414% |
| HeartBeam, Inc. | - USD | -Infinity% |
| CareCloud, Inc. | 14.73 Million USD | -164.413% |
| Mangoceuticals, Inc. | 128.67 Thousand USD | -30174.017% |
| CareMax, Inc. | 491.93 Million USD | 92.081% |
| Healthcare Triangle, Inc. | 4.31 Million USD | -802.386% |
| Aclarion, Inc. | 1.12 Million USD | -3360.529% |
| OptimizeRx Corporation | 36.82 Million USD | -5.79% |